Application of Hepatoprotector Remaxol in the Treatment of Patients Co-Infected with Tuberculosis, HIV, and Chronic Hepatitis C

Application of Hepatoprotector Remaxol in the Treatment of Patients Co-Infected with Tuberculosis, HIV, and Chronic Hepatitis C

Objective: to study effectiveness of remaxol inclusion in pathogenetic therapy scheme for patients with pulmonary tuberculosis and HIV infection in combination with Chronic hepatitis C against the background of alcohol- and drug-related liver damage. Material and methods: 132 case histories of patie...

Full description

Saved in:

Bibliographic Details
Main Authors:	YU. G. Pritulina, G. V. Fil, S. V. Kornienko, N. V. Plokhotnyuk
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	tuberculosis hiv infection viral hepatitis c pathogenetic therapy remaxol hepatotropic effect
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/126
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Remaxol Hepatoprotective Therapy of Patients with Tuberculosis and HIV Infection in Day Unit of Tuberculosis Dispensary
by: E. V. Shevyreva, et al.
Published: (2020-05-01)

Hepatotropic Therapy in Treatment of Liver Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Investigation of Remaxol Efficacy in Complex Therapy of Experimental Generalized Tuberculosis on Mice
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Real-World Clinical and Economic Efficacy of Succinate-Based Therapy with Remaxol of Alcohol Hepatitis
by: L. Yu. Il’chenko, et al.
Published: (2024-02-01)

Efficiency of Remaxol Use in Supporting Treatment of Advanced Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

The feasibility of pathogenetic therapy for chronic viral hepatitis C in adult HIV-infected patients
by: E. B. Bun'kova, et al.
Published: (2024-09-01)

Remaxol in Correction of Functional Hepatic Failure in Patients with Acute Biliary Pancreatitis
by: A. P. Vlasov, et al.
Published: (2020-05-01)

Some Peculiarities of Modern Comorbid Tuberculosis Therapy
by: V. M. Kolomiets, et al.
Published: (2023-02-01)

USE OF HEPATOPROTECTORS IN PATIENTS WITH OVARIAN CANCER
by: S. V. Tumanyan, et al.
Published: (2015-05-01)

CHRONIC VIRAL HEPATITIS, TUBERCULOSIS, AND HIV AS COMORBIDITY: FROM THEORY TO PRACTICE
by: V. V. Nechaev, et al.
Published: (2018-01-01)

EFFICACY OF REMAXOL AND ADEMETHIONINE IN EXPERIMENTAL LIVER DAMAGE CAUSED BY A COMBINATION OF RESERVE-SERIES ANTITUBERCULOSIS DRUGS AND ALCOHOL
by: D. S. Sukhanov, et al.
Published: (2014-04-01)

The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
by: V. M. Kolomiets, et al.
Published: (2020-12-01)

REMAXOL: MECHANISMS OF ACTION AND APPLICATION IN REAL CLINICAL PRACTICE
by: L. Yu. Ilchenko, et al.
Published: (2016-05-01)

Pharmacoeconomic Analysis of the Use of Hepatoprotectors in Management of Drug-Associated Liver Injury Due to Hodgkin's Lymphoma Chemotherapy
by: D. D. Morikov, et al.
Published: (2020-05-01)

Prevalence of Co-infection of Hepatitis B Virus and Hepatitis C Virus among Human Immunodeficiency Virus Patients on Antiretroviral Therapy at A Tertiary Care Centre, Eluru, Andhra Pradesh, India
by: V. Manjula, et al.
Published: (2024-12-01)

THE FIRST TWO CASES OF CHRONIC HEPATITIS ASSOCIATED WITH TORQUE TENO MIDI VIRUS (TTMDV), GENUS GAMMATORQUEVIRUS
by: I. A. Morozov, et al.
Published: (2017-03-01)

Predictors of unfavourable treatment outcomes for HIV-associated MDR-TB in patients with viral hepatitis C
by: A. V. Kukurika
Published: (2024-07-01)

Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis
by: S. V. Kornienko, et al.
Published: (2015-02-01)

Effectiveness and Safety of New Chemotherapy Regimens in Patients with HIV-associated MDR TB and Viral Hepatitis C
by: A. V. Kukurika, et al.
Published: (2024-12-01)

DRUG-INDUCED LIVER LESIONS AND THEIR MANAGEMENT IN THE MANIFESTATIONS OF TUBERCULOSIS
by: A. V. Mordyk, et al.
Published: (2015-09-01)

Effect of dalargin and remaxol on endocrine and metabolic disorders in patients with thoracoabdominal trauma
by: A. G. Miroshnichenko, et al.
Published: (2021-05-01)

Clinical observation of Kaposi sarcoma associated with HIV in a patient with disseminated pulmonary tuberculosis, viral hepatitis B and C
by: N. V. Nelidova, et al.
Published: (2021-12-01)

Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Comparative Efficacy of Clinical Use of Reamberin, Remaxol and Ademethionine in Patients with Tuberculosis of the Respiratory Organs and Liver Drug-Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Comorbid Tuberculosis in the Context of the Formation of a Local Epidemic Situation
by: V. M. Kolomiets, et al.
Published: (2025-02-01)

The Problem of Comorbid Socially Significant Infections Under The Conditions of The COVID-19 Pandemic
by: V. M. KOLOMIETS, et al.
Published: (2022-11-01)

The kidney diseases associated with HIV infection and coinfection with viral hepatitis B and C. Case report
by: Alexey Yu. Martynov, et al.
Published: (2024-11-01)

The eﬀectiveness of psychological support with the use of hepato-immunoprotectors as predictors in drug therapy of tuberculosis
by: V. M. Kolomiets, et al.
Published: (2021-08-01)

Coinfection of hepatitis B, tuberculosis, and HIV/AIDS in Beijing from 2016 to 2023: a surveillance data analysis
by: Chao Wang, et al.
Published: (2025-04-01)

Retrospective Analysis of Experimental and Clinical Studies of Flakozid in Viral Hepatitis
by: V. V. Karabaeva, et al.
Published: (2021-11-01)

ACTUAL PRINCIPLES OF THERAPY CHRONIC HEPATITIS OF VARIOUS ETIOLOGIES
by: I. V. Semenova, et al.
Published: (2015-12-01)

Metaanalytic Approach to Evaluate Clinical Effectiveness of Infusion Succinnate-Containing Remaxol in Liver Pathologies of Diverse Genesis
by: N. K. Mazina, et al.
Published: (2020-05-01)

Genotypic Diversity of Hepatitis C Virus in Tuberculosis Patients in the Tomsk Region
by: K. A. Svirin, et al.
Published: (2025-03-01)

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01)

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01)

The Incidence of Osteoarticular Tuberculosis in the Siberian and Far Eastern Federal Districts in 2018-2020
by: Sh. N. Rakhmatillaev, et al.
Published: (2022-11-01)

Surgical treatment of pulmonary tuberculosis in patients with concurrent parenteral viral hepatitis
by: S. N. Shugаevа, et al.
Published: (2020-07-01)

TUBERCULOSIS WITH CONCURRENT HIV INFECTION IN RUSSIA: STATISTICS AND CORRELATIONS
by: E. B. Tsybikova, et al.
Published: (2019-01-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological responseResearch in context
by: Jésica Martín-Carmona, et al.
Published: (2025-05-01)